openbell openbell

Financial news scored by AI. No noise, no delay. Latest: Apollomics Announces Layoffs and Termination of Lung Cancer Trial Due to Cash Constraints (Impact: -85). OpenBell scores breaking market news for potential price impact, so you can see why it matters, not just that it happened.

Financial News with AI Impact Scores

Get real-time financial news with AI-powered impact analysis delivered through Discord

Today's Market Overview

openbell provides real-time news intelligence for smarter trades. Latest stories cover Healthcare, Industrials, Consumer Defensive, Technology, Consumer Cyclical sectors. Top story: "Apollomics Announces Layoffs and Termination of Lung Cancer Trial Due to Cash Constraints" with -85 impact score. Join our Discord community for real-time alerts and discussions.

Latest News

Healthcare -85 APLM

Apollomics Announces Layoffs and Termination of Lung Cancer Trial Due to Cash Constraints

Apollomics said in an SEC filing that severe cash constraints are prompting it to lay off all U.S. employees, including its CEO and CFO, and end operations related to its lung cancer clinical trial. The moves follow a failed late-stage blood cancer trial that did not show a survival benefit over chemotherapy alone. The company has scheduled an extraordinary shareholder meeting to vote on liquidation.

Industrials -60 JELD

JELD-WEN Reports Q3 2026 Results, Strategic Review Outcome, and CFO Departure

JELD-WEN reported higher adjusted earnings in Q3 2026, aided by tariff refunds and cost savings, despite weaker-than-expected demand for windows and doors. After a strategic review, it will retain its European business and pursue operational improvements under Christian Michel; CFO Stoddard is stepping down. The company maintained its full-year revenue and adjusted EBITDA guidance but now expects market volumes to decline in North America and Europe. It expects to complete debt refinancing by the end of November, extending maturities to 2031 while adding about $50 million in annual interest expense.

Consumer Defensive +60 FC

Franklin Covey Reports Fiscal 2026 Financial Results and Fiscal 2027 Outlook

Franklin Covey reported fiscal 2026 revenue of $261.5 million, down 2% year over year, while adjusted EBITDA edged up to $28.9 million. Fourth-quarter revenue was $70 million, and adjusted EBITDA increased 9% to $12.8 million. For fiscal 2027, the company forecasts revenue of $263 million to $273 million and adjusted EBITDA of $29 million to $34 million, plans to expand its sales hunting team by more than 20%, and expects to complete the transition of its China operations to a locally owned licensee by the end of the second quarter. Franklin Covey also repurchased about 1.6 million shares for $28.1 million during fiscal 2026.

Consumer Cyclical +68 HLT

Hilton Raises Full-Year Revenue Per Available Room (RevPAR) Forecast

Hilton raised its full-year RevPAR growth forecast to 4%–4.5%, up from its prior guidance of 3%–3.5%. Leadership attributed the improved outlook to resilient global travel demand, while CEO Christopher Nassetta said business activity in the Middle East has been slightly softer than expected.

Basic Materials +68 MLM

Martin Marietta Announces 2027 Margin Growth Outlook and $500 Million Debt Repayment Plan

Martin Marietta Materials projected aggregate pricing growth and margin expansion in 2027, supported by cost management, network optimization, and a full year of earnings from Lhoist, which it expects to help offset inflation. The company plans to repay approximately $500 million in debt over the coming weeks. It reaffirmed its commitment to an investment-grade credit rating and a target net debt-to-adjusted EBITDA ratio of 2.0 to 2.5.

Load More News